April 2010 — “Edward M. Marcotte is looking for drugs that can kill tumors by stopping blood vessel growth, and he and his colleagues at the University of Texas at Austin recently found some good targets — five human genes that are essential for that growth. Now they’re hunting for drugs that can stop those genes from working. Strangely, though, Dr. Marcotte did not discover the new genes in the human genome, nor in lab mice or even fruit flies. He and his colleagues found the genes in yeast."
CSSB Built Autonomous Nano-robot from DNA
Could one day be used to roam human body as cancer detector...
Molecular Tool Kit Shared Across Tree of Life
In one of the largest and most detailed studies of animal molecular biology ever undertaken, researchers at The University of Texas at Austin and the University of Toronto discovered the assembly instructions for nearly 1,000 protein complexes shared by most kinds of animals, revealing their deep evolutionary relationships.
Dr. Ellington receives Gates Foundation grant for TB test
November 2011 — “Developing a simple, paper-based test for drug-resistant tuberculosis (TB) is the goal of a University of Texas at Austin chemist, whose project just received a $1.6 million point-of-care diagnostics grant through Grand Challenges in Global Health, an initiative created by the Bill & Melinda Gates Foundation
Dr. Sullivan Aims to Hunt and Destroy Latent Viruses
Although his goal is to someday help destroy HIV and other viruses and retroviruses that form persistent, lifelong infections, biologist Chris Sullivan can’t help but admire the strategies that many of these viruses have evolved to evade our defenses.
The Center for systems and Synthetic Biology (CSSB) brings together UT researchers across a range of disciplines to quantitatively understand and engineer the regulatory networks underlying organismal biology.
Hot Science, Cool Talks: Self Diagnostics. Dr. Ellington spoke with the local Austin community about how modern science will provide solutions to low-resource communities, the burgeoning medical needs of an aging population, and our commercial wants and desires. April 4, 2013.